Regulatory Guidance

Jury awards man $8B for claims a J&J drug made him grow breasts

Oct 09, 2019

A Philadelphia jury has ordered Johnson & Johnson to pay a whopping $8 billion for a claim that the company failed to warn patients about serious side effects associated with an anti-psychotic drug.

The lawsuit was brought against the drugmaker after a man said that he began taking Risperdal as a child and then developed an incurable condition called gynecomastia, which causes men to develop breasts. The suit is one of about 13,000 that have been levied against J&J for similar claims. 

Analysts have called this recent verdict “excessive,” especially because the plaintiff has already been awarded $680,000 in compensatory damages. But many analysts also believe that the $8 billion penalty will most likely be lowered in further court proceedings.

J&J has already paid out $2.2 billion to settle criminal and civil investigations by the U.S. Department of Justice for its marketing of Risperdal.

Read the full Reuters report.

Don't miss your Daily Dose. Get news like this delivered right to your inbox.